
Acceptable tolerability observed in first-in-human study Encouraging initial anti-leukemic activity observed in relapsed/refractory AML ...

Updated Clinical Data from Original Part 1 of IMerge in Myelodysplastic Syndromes (MDS) PresentedMENLO ...
Click to continue to site. Closing